Shoei Furukawa Selected Research

royal jelly

1/2011	Royal jelly facilitates restoration of the cognitive ability in trimethyltin-intoxicated mice.
3/2010	AMP N(1)-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase.
12/2007	AMP N1-oxide potentiates astrogenesis by cultured neural stem/progenitor cells through STAT3 activation.
6/2007	Royal jelly-induced neurite outgrowth from rat pheochromocytoma PC12 cells requires integrin signal independent of activation of extracellular signal-regulated kinases.
4/2006	Identification of AMP N1-oxide in royal jelly as a component neurotrophic toward cultured rat pheochromocytoma PC12 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shoei Furukawa Research Topics

Disease

10	Spinal Cord Injuries (Spinal Cord Injury) 10/2017 - 06/2002
9	Pheochromocytoma 09/2012 - 04/2006
3	Mood Disorders (Mood Disorder) 03/2015 - 01/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2006 - 05/2004
2	Wounds and Injuries (Trauma) 10/2017 - 02/2005
2	Mental Disorders (Mental Disorder) 01/2015 - 12/2010
2	Inflammation (Inflammations) 10/2005 - 02/2005
1	Neurodevelopmental Disorders 01/2019
1	Autism Spectrum Disorder 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2017
1	Paralysis (Palsy) 01/2015
1	Pain (Aches) 11/2014
1	Chronic Pain 11/2014
1	Hand Injuries (Hand Injury) 10/2012
1	Cerebral Infarction 01/2012
1	Urticaria (Hives) 02/2011
1	Cognitive Dysfunction 01/2011
1	Blister (Bulla) 11/2008
1	Parkinson Disease (Parkinson's Disease) 05/2004
1	Alzheimer Disease (Alzheimer's Disease) 05/2004
1	Neuroblastoma 05/2004
1	Embolism (Embolus) 05/2002
1	Brain Ischemia (Cerebral Ischemia) 05/2002
1	Neoplasms (Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

7	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017 - 01/2002
7	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2015 - 05/2004
6	Nerve Growth Factors (Neurotrophins)IBA 01/2015 - 03/2006
5	royal jellyIBA 01/2011 - 04/2006
4	Mitogen-Activated Protein KinasesIBA 12/2011 - 07/2006
4	AMP N1-oxideIBA 03/2010 - 04/2006
3	Pharmaceutical PreparationsIBA 01/2019 - 05/2004
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2017 - 09/2014
2	2-decenoic acidIBA 01/2015 - 01/2012
2	Messenger RNA (mRNA)IBA 10/2012 - 05/2004
2	Nerve Growth Factor (NGF)IBA 09/2012 - 06/2002
2	EnzymesIBA 02/2011 - 06/2002
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2011 - 10/2005
2	Propolis (Bee Bread)IBA 02/2011 - 01/2011
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 03/2010 - 06/2007
2	Neuroprotective AgentsIBA 03/2010 - 05/2004
2	Adenosine Monophosphate (AMP)IBA 03/2010 - 12/2007
2	Proteins (Proteins, Gene)FDA Link 02/2008 - 05/2004
2	LipopolysaccharidesIBA 10/2005 - 02/2005
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2017
1	Fluvoxamine (Luvox)FDA LinkGeneric 03/2015
1	CorticosteroneIBA 03/2015
1	Imipramine (Janimine)FDA LinkGeneric 11/2014
1	Serotonin (5 Hydroxytryptamine)IBA 11/2014
1	Antidepressive Agents (Antidepressants)IBA 11/2014
1	EstersIBA 01/2012
1	Protein Kinases (Protein Kinase)IBA 12/2011
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2011
1	CytokinesIBA 02/2011
1	caffeic acid phenethyl esterIBA 02/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2011
1	Ethanol (Ethyl Alcohol)IBA 01/2011
1	Carisoprodol (Soma)FDA LinkGeneric 11/2008
1	ebselenIBA 02/2008
1	SeleniumIBA 02/2008
1	IntegrinsIBA 06/2007
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2007
1	Selenium CompoundsIBA 01/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2005
1	Interleukin-2 (IL2)IBA 10/2004
1	Concanavalin AIBA 10/2004
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2004
1	rasagiline (Azilect)FDA Link 05/2004
1	Transcription Factors (Transcription Factor)IBA 05/2004
1	N-propargylIBA 05/2004
1	NF-kappa B (NF-kB)IBA 05/2004
1	GAP-43 Protein (GAP 43 Protein)IBA 05/2002

Therapy/Procedure

1	Denervation 11/2014
1	Analgesia 11/2014
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2014
1	Autologous Transplantation 09/2014
1	Microspheres (Microsphere) 05/2002